Kala Bio Inc
(KALA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KALA | CELZ | CYCN | ||
| Company | Kala Bio Inc | Creative Medical Technology Holdings Inc | Cyclerion Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.4408 | 1.9200 | 1.1100 | ||
| High | 0.4634 | 1.9700 | 1.1900 | ||
| Low | 0.4000 | 1.8300 | 1.0266 | ||
| Latest | 0.4150 | 1.9000 | 1.1700 | ||
| Change | -0.0250 | -0.0300 | +0.0700 | ||
| % Change | -5.68% | -1.55% | +6.36% | ||
| Volume | 747,900 | 14,700 | 82,700 | ||
| 20-Day Average Volume | 1,010,655 | 103,975 | 144,520 | ||
| Previous Close | 0.4400 | 1.9300 | 1.1000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.5538 | 2.0010 | 1.3735 | ||
| 20-Day Raw Stochastic | 10.58% | 33.85% | 17.42% | ||
| 20-Day Relative Strength | 34.47 | 43.55 | 40.77 | ||
| Weighted Alpha | -62.77 | -52.69 | -68.95 | ||
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 80% Sell | 64% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -21.33% since 02/02/26 | -8.65% since 02/02/26 | -15.22% since 02/02/26 | ||
| Low | 0.3801 on 02/05/26 | 1.7800 on 02/05/26 | 1.0266 on 02/09/26 | ||
| High | 0.5500 on 02/03/26 | 2.1200 on 02/03/26 | 1.5200 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | -34.28% since 01/09/26 | -15.56% since 01/09/26 | -29.09% since 01/09/26 | ||
| Low | 0.3801 on 02/05/26 | 1.6800 on 01/14/26 | 1.0266 on 02/09/26 | ||
| High | 0.7100 on 01/16/26 | 2.3299 on 01/13/26 | 1.8500 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | -41.87% since 11/07/25 | -37.09% since 11/07/25 | -27.87% since 11/07/25 | ||
| Low | 0.3801 on 02/05/26 | 1.5040 on 12/29/25 | 1.0266 on 02/09/26 | ||
| High | 1.9100 on 12/01/25 | 3.3399 on 11/10/25 | 2.2800 on 01/06/26 | ||
| 6-Month | |||||
| %Chg | -94.38% since 08/08/25 | -42.94% since 08/08/25 | -48.94% since 08/08/25 | ||
| Low | 0.3801 on 02/05/26 | 1.5040 on 12/29/25 | 1.0266 on 02/09/26 | ||
| High | 20.6000 on 09/17/25 | 6.2500 on 10/28/25 | 3.7600 on 09/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,325 | 4,980 | 4,318 | ||
| Shares Outstanding, K | 9,830 | 2,580 | 3,925 | ||
| Annual Sales | 0 | 10,000 | 2,000,000 | ||
| Annual Net Income | -38,510,000 | -5,490,000 | -3,060,000 | ||
| Last Quarter Sales | 0 | 0 | 880,000 | ||
| Last Quarter Net Income | -7,560,000 | -1,240,000 | -980,000 | ||
| 60-Month Beta | -2.43 | 2.08 | 0.98 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.07 on 11/19/25 | -0.48 on 11/07/25 | -0.30 on 11/12/25 | ||
| Latest Earnings Date | 03/30/26 | 03/13/26 | 03/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||